€200m pharma plan for Cork frozen by Trump fears

Project stalled as Eli Lilly awaits further information about new president's plans for industry

12th February, 2017

Pharmaceutical giant Eli Lilly has delayed a €200 million investment in Cork amid fears of a clampdown on the pharmaceutical sector by the newly elected US president Donald Trump.

A number of sources in Cork have confirmed to The Sunday Business Post that the project has been stalled as Eli Lilly awaits further information about Trump’s plans for its industry.

The new investment would create hundreds of jobs.

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The Big Interview: Brian Stafford, chief executive of Diligent Corporation

Elaine Byrne: Ethics watchdog is a bystander when it comes to misbehaviour

Editorial: Voters reluctant to fork out for full cost of a united Ireland